Group One Trading, L.P. Alaunos Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.12 - $0.5 $2,968 - $12,367	-24,734 Reduced 9.6%	232,806 $30,000
Q2 2023 Aug 09, 2023	BUY	$0.43 - $0.65 $43,532 - $65,805	101,239 Added 64.77%	257,540 $131,000
Q1 2023 May 12, 2023	SELL	$0.46 - $0.81 $52,610 - $92,639	-114,370 Reduced 42.25%	156,301 $98,000
Q4 2022 Feb 09, 2023	SELL	$0.5 - $261.0 $85,780 - $44.8 Million	-171,561 Reduced 38.79%	270,671 $175,000
Q3 2022 Nov 09, 2022	BUY	$1.04 - $322.5 $151,880 - $47.1 Million	146,039 Added 49.31%	442,232 $761,000
Q2 2022 Aug 11, 2022	BUY	$0.41 - $1.24 $12,700 - $38,412	30,978 Added 11.68%	296,193 $367,000
Q1 2022 May 12, 2022	BUY	$0.62 - $1.17 $42,905 - $80,966	69,202 Added 35.3%	265,215 $173,000
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $70,395 - $122,061	64,583 Added 49.14%	196,013 $214,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $37,130 - $70,393	-25,785 Reduced 16.4%	131,430 $239,000
Q2 2021 Aug 10, 2021	BUY	$2.63 - $3.67 $282,401 - $394,073	107,377 Added 215.45%	157,215 $415,000
Q1 2021 May 12, 2021	SELL	$2.82 - $5.6 $330,016 - $655,351	-117,027 Reduced 70.13%	49,838 $179,000
Q4 2020 Feb 10, 2021	BUY	$2.09 - $3.09 $267,758 - $395,872	128,114 Added 330.61%	166,865 $421,000
Q3 2020 Nov 12, 2020	BUY	$2.39 - $3.43 $15,016 - $21,550	6,283 Added 19.35%	38,751 $98,000
Q2 2020 Aug 13, 2020	SELL	$2.2 - $3.71 $11,578 - $19,525	-5,263 Reduced 13.95%	32,468 $107,000
Q1 2020 May 13, 2020	SELL	$1.9 - $4.98 $496,221 - $1.3 Million	-261,169 Reduced 87.38%	37,731 $92,000
Q4 2019 Feb 10, 2020	SELL	$3.95 - $5.35 $243,343 - $329,592	-61,606 Reduced 17.09%	298,900 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $266,525 - $447,865	64,534 Added 21.8%	360,506 $1.54 Million
Q2 2019 Aug 09, 2019	BUY	$3.98 - $6.2 $456,812 - $711,617	114,777 Added 63.34%	295,972 $1.73 Million
Q1 2019 May 13, 2019	SELL	$2.0 - $4.4 $370,638 - $815,403	-185,319 Reduced 50.56%	181,195 $698,000
Q4 2018 Feb 06, 2019	BUY	$1.61 - $3.62 $38,467 - $86,492	23,893 Added 6.97%	366,514 $685,000
Q3 2018 Nov 08, 2018	SELL	$2.26 - $3.27 $38,456 - $55,642	-17,016 Reduced 4.73%	342,621 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $524,670 - $858,236	173,732 Added 93.45%	359,637 $1.09 Million
Q1 2018 May 11, 2018	SELL	$3.46 - $5.14 $239,909 - $356,397	-69,338 Reduced 27.17%	185,905 $729,000
Q4 2017 Feb 09, 2018	SELL	$4.0 - $6.54 $294,768 - $481,945	-73,692 Reduced 22.4%	255,243 $1.06 Million
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $709,044 - $933,551	142,093 Added 76.05%	328,935 $2.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	186,842	186,842 $1.16 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account